AAAAAA

   
Results: 1-10 |
Results: 10
OPTIMAL MANAGEMENT OF AMIODARONE THERAPY - EFFICACY AND SIDE-EFFECTS
Authors: HILLEMAN D MILLER MA PARKER R DOERING P PIEPER JA
Citation: D. Hilleman et al., OPTIMAL MANAGEMENT OF AMIODARONE THERAPY - EFFICACY AND SIDE-EFFECTS, Pharmacotherapy, 18(6), 1998, pp. 138-145
EFFECTS OF ERYTHROMYCIN OR RIFAMPIN ON LOSARTAN PHARMACOKINETICS IN HEALTHY-VOLUNTEERS
Authors: WILLIAMSON KM PATTERSON JH MCQUEEN RH ADAMS KF PIEPER JA
Citation: Km. Williamson et al., EFFECTS OF ERYTHROMYCIN OR RIFAMPIN ON LOSARTAN PHARMACOKINETICS IN HEALTHY-VOLUNTEERS, Clinical pharmacology and therapeutics, 63(3), 1998, pp. 316-323
THE EFFECTS OF FLUVASTATIN, A CYP2C9 INHIBITOR, ON LOSARTAN PHARMACOKINETICS
Authors: MEADOWCROFT AM WILLIAMSON KM PATTERSON JH HINDERLITER AL PIEPER JA
Citation: Am. Meadowcroft et al., THE EFFECTS OF FLUVASTATIN, A CYP2C9 INHIBITOR, ON LOSARTAN PHARMACOKINETICS, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 23-23
DEXTROMETHORPHAN (DM) AND CORTISOL METABOLIC RATIOS - CORRELATES OF CYP3A4 ACTIVITY
Authors: LINDLEY C DECKER J MCCUNE J KASHUBA A MEADOWCROFT A HALL W PATTERSON JH PIEPER JA
Citation: C. Lindley et al., DEXTROMETHORPHAN (DM) AND CORTISOL METABOLIC RATIOS - CORRELATES OF CYP3A4 ACTIVITY, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 42-42
PHARMACY FELLOWSHIP PROGRAMS IN THE UNITED-STATES - PERCEPTIONS FROM FELLOWS AND PRECEPTORS
Authors: RHONEY DH BROOKS VG PATTERSON JH PIEPER JA
Citation: Dh. Rhoney et al., PHARMACY FELLOWSHIP PROGRAMS IN THE UNITED-STATES - PERCEPTIONS FROM FELLOWS AND PRECEPTORS, American journal of pharmaceutical education, 62(3), 1998, pp. 290-296
PHARMACOGENETICS AND HEART-FAILURE - A CONVERGENCE WITH CARVEDILOL
Authors: MEADOWCROFT AM WILLIAMSON KM PATTERSON JH PIEPER JA
Citation: Am. Meadowcroft et al., PHARMACOGENETICS AND HEART-FAILURE - A CONVERGENCE WITH CARVEDILOL, Pharmacotherapy, 17(4), 1997, pp. 637-639
CALCIUM-CHANNEL BLOCKERS - THE PRESENT AND THE FUTURE
Authors: PIEPER JA
Citation: Ja. Pieper, CALCIUM-CHANNEL BLOCKERS - THE PRESENT AND THE FUTURE, Pharmacotherapy, 17(2), 1997, pp. 408-412
EFFECTS OF ERYTHROMYCIN OR RIFAMPIN ON STEADY-STATE LOSARTAN PHARMACOKINETICS IN HEALTHY-VOLUNTEERS
Authors: WILLIAMSON KM PATTERSON JH PIEPER JA MCQUEEN RH ADAMS KF
Citation: Km. Williamson et al., EFFECTS OF ERYTHROMYCIN OR RIFAMPIN ON STEADY-STATE LOSARTAN PHARMACOKINETICS IN HEALTHY-VOLUNTEERS, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 31-31
EVOLVING ROLE OF CALCIUM-CHANNEL BLOCKERS IN HEART-FAILURE
Authors: PIEPER JA
Citation: Ja. Pieper, EVOLVING ROLE OF CALCIUM-CHANNEL BLOCKERS IN HEART-FAILURE, Pharmacotherapy, 16(2), 1996, pp. 43-49
ABSORPTION PHARMACOKINETICS OF ATENOLOL IN PATIENTS WITH THE MARFAN-SYNDROME
Authors: PHELPS SJ ALPERT BS WARD JL PIEPER JA LIMA JJ
Citation: Sj. Phelps et al., ABSORPTION PHARMACOKINETICS OF ATENOLOL IN PATIENTS WITH THE MARFAN-SYNDROME, Journal of clinical pharmacology, 35(3), 1995, pp. 268-274
Risultati: 1-10 |